Eliminating residual iPS cells for safety in clinical application

Huskey NE et al (2015) CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Rep 4:374–389

Masuda S et al (2014) Emerging innovation towards safety in the clinical application of ESCs and iPSCs. Nat Rev Cardiol 11:553–554

Tateno H et al (2011) Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem 286:20345–20353

Tateno H et al (2015) Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein. Stem Cell Rep. doi: 10.1016/j.stemcr.2015.02.016

Wu T, Pinto HB, Kamikawa YF, Donohoe ME (2015) The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression. Stem Cell Rep 4:390–403